Long intergenic non-protein coding RNA 1737 (LINC01737)

Long intergenic non-protein coding RNA 1737 (LINC01737) is a member of the long non-coding RNA (lncRNA) class, specifically classified as a long intergenic non-coding RNA (lincRNA)[1][3]. LincRNAs are defined as RNA transcripts longer than 200 nucleotides that are not translated into protein and do not overlap with protein-coding genes. Many lincRNAs have emerging roles in gene regulation at transcriptional and post-transcriptional levels, though the specific function of LINC01737 has not been experimentally established[1][3][7]. There is currently no evidence that LINC01737 is a therapeutic target, nor is it associated with validated pharmacological agents, mechanisms, or clear disease roles in the curated literature. This distinguishes LINC01737 from other lncRNAs that may act as disease biomarkers or functional regulators in cancer and other diseases. References: - GeneCards describes LINC01737 as a long intergenic non-protein coding RNA but does not indicate it is a therapeutic target or disease biomarker[1]. - BioGPS provides gene/protein information but no evidence supporting a therapeutic target role for LINC01737[3]. - Literature on lincRNAs generally finds these genes to be diverse regulators of gene expression, but most remain uncharacterized at a functional and therapeutic level[7]. - Importantly, search result [5] covers the related LINC00173, not LINC01737, highlighting the necessity of gene-specific review. No errors or major ambiguities in the identification and naming of LINC01737 are noted, though functionally it remains poorly characterized.

Other names

LINC01737Long intergenic non-protein coding RNA 1737